オプション
家 AIプロンプト一覧 医療健康 糖尿病患者の在宅食事プラン作成

糖尿病患者の在宅食事プラン作成

{:__('collect %s',糖尿病患者の在宅食事プラン作成)}

重篤な合併症のない2型糖尿病の成人患者向けに、中国居民膳食ガイドラインに準拠した個別化された1週間の在宅食事プランを作成し、三食の献立、注意点と食事提案を含みます

プロンプト内容 コピー コピー

Based on the height, weight, daily activity level and flavor preference provided by an adult patient with type 2 diabetes, generate a weekly three-meal home diet plan that meets Chinese dietary guidelines, mark approximate calorie and carbohydrate content for each recipe, and also list foods to avoid and daily dietary precautions.

コピー コピー

2型糖尿病の成人患者から提供された身長、体重、日常活動量、味の好みに基づき、中国居民膳食ガイドラインに準拠した1週間の在宅三食食事プランを作成し、各レシピにおおよそのカロリーと炭水化物量を記載し、避けるべき食品と日常の食事における注意点もまとめます。

コピー コピー
コメント (0)
0/300

おすすめ

処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Consider the patient's age, liver/kidney function, and allergy history to highlight potential risks and provide adjustment suggestions, ensuring the treatment plan aligns with the latest clinical guidelines.
処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract drug names, dosages, routes, and frequencies, cross-referencing them with the patient's age, renal/hepatic function, and allergy history. Second, check for drug interactions, contraindications, or off-label usage risks based on current clinical guidelines. Finally, if potential risks are identified, clearly specify the risk type and provide specific adjustment suggestions or alternative solutions, ensuring the output is concise, professional, and adheres to medical safety standards.
処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all drug names with dosages. Second, cross-reference these details against the latest clinical guidelines and package inserts to check for contraindications, drug-drug interactions, or dosage errors. Finally, if any safety risks are identified, clearly specify the risk and provide evidence-based adjustment suggestions or alternative therapies to support clinical decision-making.
処方箋審査アシスタント
Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and a newly prescribed Ibuprofen 400mg three times daily for joint pain. Analyze whether this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, particularly regarding the risk of using non-steroidal anti-inflammatory drugs in patients with renal insufficiency, and provide specific adjustment suggestions or alternative solutions to ensure medication safety.
処方箋審査アシスタント
Act as a senior clinical pharmacist and review the following simulated prescription: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and Ibuprofen 400mg tid (for osteoarthritis pain). Analyze if there are drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the risks of NSAID use in patients with renal impairment, and provide specific adjustment suggestions or alternative plans to ensure medication safety and compliance with clinical guidelines.
処方箋審査アシスタント
Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 Hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and a newly prescribed Ibuprofen 400mg tid. Analyze if this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the impact of NSAIDs on renal function and the combined risk with antiplatelet agents, and provide specific adjustment suggestions or warning information to ensure the safety and efficacy of the medication regimen.
OR